SHU FENG

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pathology & Immunology
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shao L, Wang J, Karatas OF, Feng S, Zhang Y, Creighton CJ, Ittmann M. Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN. Oncotarget. 2018 Mar 06; 9(18):14456-14471. PMID: 29581856.
      Citations: 2     Fields:    
    2. Ban K, Feng S, Shao L, Ittmann M. RET Signaling in Prostate Cancer. Clin Cancer Res. 2017 Aug 15; 23(16):4885-4896. PMID: 28490466.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    3. Feng S, Shao L, Castro P, Coleman I, Nelson PS, Smith PD, Davies BR, Ittmann M. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors. Oncotarget. 2017 Jan 24; 8(4):6179-6192. PMID: 28008155.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    4. Feng S, Kroll MH, Nick AM, Sood AK, Afshar-Kharghan V. Platelets are not hyperreactive in patients with ovarian cancer. Platelets. 2016 Nov; 27(7):716-718. PMID: 27185008.
      Citations: 2     Fields:    Translation:HumansCells
    5. Feng S, Wang J, Zhang Y, Creighton CJ, Ittmann M. FGF23 promotes prostate cancer progression. Oncotarget. 2015 Jul 10; 6(19):17291-301. PMID: 26019137.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    6. Feng S, Liang X, Kroll MH, Chung DW, Afshar-Kharghan V. von Willebrand factor is a cofactor in complement regulation. Blood. 2015 Feb 05; 125(6):1034-7. PMID: 25395424.
      Citations: 12     Fields:    Translation:HumansCells
    7. Feng S, Eyler SJ, Zhang Y, Maga T, Nester CM, Kroll MH, Smith RJ, Afshar-Kharghan V. Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome. Blood. 2013 Aug 22; 122(8):1487-93. PMID: 23847193.
      Citations: 27     Fields:    Translation:Humans
    8. Feng S, Dakhova O, Creighton CJ, Ittmann M. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res. 2013 Apr 15; 73(8):2551-62. PMID: 23440425.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    9. Feng S, Shao L, Yu W, Gavine P, Ittmann M. Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression. Clin Cancer Res. 2012 Jul 15; 18(14):3880-8. PMID: 22573348.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    10. Feng S, Agoulnik AI. Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis. Int J Oncol. 2011 Dec; 39(6):1559-65. PMID: 21842120.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    11. Yu W, Feng S, Dakhova O, Creighton CJ, Cai Y, Wang J, Li R, Frolov A, Ayala G, Ittmann M. FGFR-4 Arg³88 enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res. 2011 Jul 01; 17(13):4355-66. PMID: 21622724.
      Citations: 24     Fields:    Translation:HumansCells
    12. Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, Pereira R, Han HD, Lopez-Berestein G, Klonisch T, Ittmann MM, Sood AK, Agoulnik AI. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr Relat Cancer. 2010 Dec; 17(4):1021-33. PMID: 20861284.
      Citations: 21     Fields:    Translation:AnimalsCells
    13. Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci. 2009 Apr; 1160:379-80. PMID: 19416223.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    14. Feng S, Ferlin A, Truong A, Bathgate R, Wade JD, Corbett S, Han S, Tannour-Louet M, Lamb DJ, Foresta C, Agoulnik AI. INSL3/RXFP2 signaling in testicular descent. Ann N Y Acad Sci. 2009 Apr; 1160:197-204. PMID: 19416188.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    15. Li Z, Burzawa JK, Troung A, Feng S, Agoulnik IU, Tong X, Anderson ML, Kovanci E, Rajkovic A, Agoulnik AI. Relaxin signaling in uterine fibroids. Ann N Y Acad Sci. 2009 Apr; 1160:374-8. PMID: 19416222.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    16. Feng S, Bogatcheva NV, Truong A, Korchin B, Bishop CE, Klonisch T, Agoulnik IU, Agoulnik AI. Developmental expression and gene regulation of insulin-like 3 receptor RXFP2 in mouse male reproductive organs. Biol Reprod. 2007 Oct; 77(4):671-80. PMID: 17615407.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    17. Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702. PMID: 17363522.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    18. Bogatcheva NV, Ferlin A, Feng S, Truong A, Gianesello L, Foresta C, Agoulnik AI. T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E138-44. PMID: 16926383.
      Citations: 23     Fields:    Translation:HumansCells
    19. Feng S, Lu X, Reséndiz JC, Kroll MH. Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. . 2006 Dec; 291(6):C1346-54. PMID: 16822941.
      Citations:    
    20. Feng S, Bogatcheva NV, Truong A, Engel W, Adham IM, Agoulnik AI. Over expression of insulin-like 3 does not prevent cryptorchidism in GNRHR or HOXA10 deficient mice. J Urol. 2006 Jul; 176(1):399-404. PMID: 16753450.
      Citations: 8     Fields:    Translation:AnimalsCells
    21. Kamat AA, Feng S, Agoulnik IU, Kheradmand F, Bogatcheva NV, Coffey D, Sood AK, Agoulnik AI. The role of relaxin in endometrial cancer. . 2006 Jan; 5(1):71-7. PMID: 16322684.
      Citations:    
    22. Feng S, Bogatcheva NV, Kamat AA, Truong A, Agoulnik AI. Endocrine effects of relaxin overexpression in mice. Endocrinology. 2006 Jan; 147(1):407-14. PMID: 16223865.
      Citations: 10     Fields:    Translation:AnimalsCells
    23. Kroll MH, Feng S. Targeting shear stress-induced platelet activation: is lesion-specific antiplatelet therapy a realistic clinical goal? Expert Rev Cardiovasc Ther. 2005 Sep; 3(5):941-51. PMID: 16181038.
      Citations: 3     Fields:    Translation:HumansAnimals
    24. Feng S, Bogatcheva NV, Kamat AA, Agoulnik AI. Genetic targeting of relaxin and insl3 signaling in mice. Ann N Y Acad Sci. 2005 May; 1041:82-90. PMID: 15956690.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    25. Feng S, Lu X, Kroll MH. Filamin A binding stabilizes nascent glycoprotein Ibalpha trafficking and thereby enhances its surface expression. J Biol Chem. 2005 Feb 25; 280(8):6709-15. PMID: 15623510.
      Citations: 16     Fields:    Translation:AnimalsCells
    26. Feng S, Cortessis VK, Hwang A, Hardy B, Koh CJ, Bogatcheva NV, Agoulnik AI. Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism. Urology. 2004 Nov; 64(5):1032-6. PMID: 15533513.
      Citations: 5     Fields:    Translation:Humans
    27. Sun L, Feng S, Reséndiz JC, Lu X, Durante W, Kroll MH. Role of the Pyk2-MAP kinase-cPLA2 signaling pathway in shear-dependent platelet aggregation. Ann Biomed Eng. 2004 Sep; 32(9):1193-201. PMID: 15493507.
      Citations: 4     Fields:    Translation:HumansCells
    28. Kamat AA, Feng S, Bogatcheva NV, Truong A, Bishop CE, Agoulnik AI. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology. 2004 Oct; 145(10):4712-20. PMID: 15256493.
      Citations: 35     Fields:    Translation:Animals
    29. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI. GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol. 2003 Dec; 17(12):2639-46. PMID: 12933905.
      Citations: 37     Fields:    Translation:AnimalsCells
    30. Reséndiz JC, Feng S, Ji G, Francis KA, Berndt MC, Kroll MH. Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation. Mol Pharmacol. 2003 Mar; 63(3):639-45. PMID: 12606772.
      Citations: 3     Fields:    Translation:HumansCells
    31. Feng S, Reséndiz JC, Christodoulides N, Lu X, Arboleda D, Berndt MC, Kroll MH. Pathological shear stress stimulates the tyrosine phosphorylation of alpha-actinin associated with the glycoprotein Ib-IX complex. Biochemistry. 2002 Jan 29; 41(4):1100-8. PMID: 11802708.
      Citations:    Fields:    Translation:HumansCells
    FENG's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (223)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _